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Short Communication
Cigarette smoking, von Hippel–Lindau gene mutations and
sporadic renal cell carcinoma
BAC van Dijk1,6, LJ Schouten1,*, E Oosterwijk2, CA Hulsbergen-van de Kaa3, LALM Kiemeney2,4,
RA Goldbohm5, JA Schalken2 and PA van den Brandt1
1Department of Epidemiology, NUTRIM, Maastricht University, PO Box 616, Maastricht 6200 MD, The Netherlands; 2Department of Urology, Radboud
University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands; 3Department of Pathology, Radboud University Nijmegen
Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands; 4Department of Epidemiology and Biostatistics, Radboud University Nijmegen
Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands; 5Department of Food and Chemical Risk Analysis, TNO Nutrition and Food
Research, PO Box 360, Zeist 3700AJ, The Netherlands
We investigated whether smoking is associated with mutations in the Von Hippel–Lindau (VHL) gene in 337 cases of sporadic renal
cell carcinoma (RCC) among 120 852 people followed for 11.3 years; the findings suggest that smoking causes RCC independently of
VHL gene mutations.
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Mutations in the von Hippel–Lindau (VHL) tumour suppressor
gene are a common, early event in sporadic clear-cell renal cell
carcinoma (RCC) (Gnarra et al, 1996; Richards et al, 1998).
Tobacco smoke is implicated in the aetiology of RCC, with dose-
dependent increased risks for former (rate ratio RR: 1.21; 95% CI:
1.07– 1.36) and current (RR: 1.45; 95% CI: 1.26–1.66) smokers
(Hunt et al, 2005). Cigarette smoke metabolites have been shown
to cause specific DNA mutations (Harris, 1991; Shiao et al, 1998;
Phillips, 2002), and are excreted in the urine (Hecht, 2002).
Occupational exposure to trichloroethylene (Brauch et al, 1999,
2004) and consumption of citrus fruit and vegetables (confined to
smokers) (Hemminki et al, 2002) have been linked to VHL
mutations in RCC. We have investigated whether cigarette
smoking is associated with sporadic RCC and with mutations in
the VHL gene in clear-cell RCC in a prospective cohort study.
MATERIALS AND METHODS
The Netherlands Cohort Study on diet and cancer (NLCS) included
120 852 men and women, aged 55– 69 years, in 1986. The study was
designed as a case–cohort study, using all cases and a random
sample of 5000 persons from the cohort (subcohort) (Van den
Brandt et al, 1990a). All participants who reported prevalent
cancer (excluding skin cancer) at baseline were excluded from
analyses (leaving 4774 subcohort members). The subcohort was
followed to estimate the accumulated person-years in the entire
cohort (Volovics and van den Brandt, 1997). Follow-up for
incident cancer was established by computerised record linkage
with the Netherlands Cancer Registry (NCR) and PALGA, a
national database of pathology reports (Van den Brandt et al,
1990b), and was estimated to be more than 96% complete
(Goldbohm et al, 1994b). From 1986 to 1997 (11.3 years follow-
up), 355 kidney cancer cases (ICD-O-3: C64.9) were identified.
Urothelial cell carcinomas were excluded and only histologically
confirmed epithelial cancers were included (ICD-O: M8010–8119,
8140– 8570), leaving 337 cases.
The collection, classification, DNA isolation and mutation
analyses have been described previously (van Houwelingen et al,
2005). After revision and VHL mutation analyses, data were
available for 235 cases.
At baseline, all cohort members completed a mailed, self-
administered questionnaire on dietary habits (food-frequency
questionnaire), lifestyle, smoking, personal and family history of
cancer and demographic data (Goldbohm et al, 1994a). Questions
on cigarette smoking in the questionnaire addressed smoking
status (never, ex- or current smoker), age at first and last exposure,
frequency and duration. Information on smoking status was
complete for 336 cases and 4762 subcohort members.
Differences between cases with and without collected tumour
material, between men and women and between cases with
and without a mutation in the VHL gene were assessed by
Student’s t-tests and w2 tests. RRs and corresponding 95%
confidence intervals (CI) were estimated using Cox proportional
hazard models processed with STATA (STATA statistical
software, Release 7, STATA Corporation, College Station, TX,
USA, 2001), after testing the proportional hazards assumption
using scaled Schoenfeld residuals (Schoenfeld, 1982). Standard
errors were estimated using the robust Huber–White sandwich
estimator to account for additional variance introduced by
sampling from the cohort (Lin and Wei, 1989). To obtain P-values
for dose– response trends, ordinal exposure variables were fitted as
continuous terms. Two-sided P-values are reported throughout
this paper.Received 24 April 2006; revised 19 June 2006; accepted 23 June 2006
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RRs were calculated for never, ex- and current smokers for the
total group and for men and women separately. The following case
groups were defined: total RCC (all cases of RCC; N¼ 337); clear-
cell RCC (all cases of RCC classified as clear-cell by one
experienced pathologist (CAHK); N¼ 187); VHL-mutated clear-
cell RCC (clear-cell RCC with a mutation in the VHL gene;
N¼ 114) and VHL wild-type clear-cell RCC (clear-cell RCC without
a mutation in the VHL gene; N¼ 73).
Because G:C-T:A transversions and G:C-A:T transitions have
been linked to specific tobacco smoke constituents (Harris, 1991;
Shiao et al, 1998), the association of smoking and these mutations
was investigated.
Confounders entered in the analyses were age, sex (if appro-
priate) and body mass index. Cigar and pipe smoking (never, ex-
and current smoker) were additionally included in the model to
account for other sources of tobacco smoke. To assess dose–
response relations, the number of cigarettes smoked per day was
categorised intoo10, 10–20, 20– 30 and 30 or more cigarettes per
day (additionally adjusted for smoking years), and the number of
smoking years was categorised into o20, 20–40 and 40 or more
smoking years (additionally adjusted for cigarettes smoked per
day). Age at first exposure (o15, 15– 17, 17–20 and 20 or older)
and years of cessation (o5, 5–20 or more than 20 years) were also
investigated, with additional adjustment for cigarettes smoked per
day.
RESULTS
Table 1 shows baseline characteristics. There were no statistically
significant differences between cases with (N¼ 235) or without
(N¼ 102) tumour tissue. The mean age was somewhat higher for
cases than for subcohort members (Table 1). There were almost no
male never smokers, whereas female smokers were scarce.
Table 2 shows multivariable adjusted analyses for smoking for
the earlier described case groups. Statistically significantly
increased RRs were observed for men only (Table 2). The RRs
were higher for VHL wild-type clear-cell tumours than for mutated
clear-cell tumours. This was observed both in men and women.
Dose–response effects were indicated (increasing risk with
increasing smoking frequency and a lower risk of RCC after
cessation without a clear trend). There were no noteworthy
differences between mutated and wild-type clear-cell RCC. This
was investigated in ever-smoking men only, as the number of
women was too low for meaningful analyses (van Dijk et al, 2006).
The distribution of smokers for the different type of mutations,
the mutational spectra, specific mutations (i.e. G:C-T:A transver-
sions and G:C-A:T transitions) and location of mutations was not
different for never, ex- and current smokers (van Dijk et al, 2006).
DISCUSSION
Our results indicate that smoking was associated with increased
risk of RCC, but that the number of mutations in the VHL gene was
not increased by smoking.
The percentage of smokers in this cohort appears to be slightly
lower compared to the percentage in the population, which may
either be the result of a selective response by smoking status to the
baseline questionnaire or of under-reporting of smoking habits
because of social desirability. The response rate to the ques-
tionnaire at baseline equalled 35.5% (Van den Brandt et al, 1990a),
with a slight shift towards nonsmoking compared to the
population (Goldbohm et al, 1991). This selective response would
not lead to altered RRs, whereas under-reporting would result in
an underestimation of the RRs.
Latency of RCC is unknown, but a latency of decades seems
plausible. Most of the ever smokers in the subcohort had smoked
Table 1 Description of possible confounding variables and smoking variables for men and women, Netherlands Cohort Study on diet and cancer, 1986–
1997
Men Women
Subcohort, RCC cases, RCC, tumour tissue, collected Subcohort, RCC cases, RCC, tumour tissue, collected
Variable N¼ 2331 N¼ 217 N¼148 N¼ 2431 N¼ 119 N¼ 87
Age, mean (s.d.) 61.4 (4.2) 62.0 (3.8) 62.2 (3.8) 61.5 (4.3) 61.8 (4.0) 61.6 (4.0)
Family history of RCC
Yes, N (%) 14 (0.6) 3 (1.4) 2 (1.4) 33 (1.4) 1 (0.8) 1 (1.2)
History of hypertension
Yes, N (%) 534 (22.9) 56 (25.8) 37 (25.0) 700 (28.8) 41 (34.5) 31 (35.6)
BMI, mean (s.d.) 25.0 (2.6) 25.3 (2.7) 25.4 (2.6) 25.1 (3.6) 25.8 (3.4) 25.7 (3.2)
(N¼ 2247) (N¼ 210) (N¼ 141) (N¼ 2341) (N¼ 113) (N¼ 82)
Cigarette smoking
Never, N (%) 300 (12.9) 18 (8.3) 12 (8.1) 1431 (58.9) 66 (55.5) 49 (56.3)
Ex, N (%) 1175 (50.4) 108 (49.8) 79 (53.4) 491 (20.2) 21 (17.6) 15 (17.2)
Current, N (%) 856 (36.7) 91 (41.9) 57 (38.5) 509 (20.9) 32 (26.9) 23 (26.4)
Never smoker
Yes N (%) 217 (9.3) 11 (5.1) 6 (4.1) 1431 (58.9) 64 (53.8) 48 (55.2)
Cigarette only smoker
Yes, N (%) 1413 (60.6) 136 (62.7) 86 (58.1) 995 (40.9) 53 (44.5) 38 (43.7)
Cigar and/or pipe smoker
Yes, N (%) 83 (3.6) 7 (3.2) 6 (4.1) 0 2 (1.7) 1 (1.2)
Cigarette and other type of tobacco smoker
Yes, N (%) 618 (26.5) 63 (29.0) 50 (33.8) 5 (0.2) 0 0
Abbreviations: BMI, body mass index; RCC, renal cell carcinoma; s.d., standard deviation.
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for 20 years or more (86.0% of men and 75.5% of women), whereas
42.2% of men and 23.7% of women had smoked for 40 years or
more. Also, 77.0% of men and 36.7% of women started smoking
before the age of 19. These percentages are sufficiently high to
assume that smoking could have caused cancer within the time
frame measured by this study.
We hypothesised smoking to be associated with VHL mutations.
Contrary to what we expected, RRs were somewhat higher for VHL
wild-type tumours than for VHL-mutated tumours. No association
of smoking and specific types of mutations was found. The
observation that exposure to BPDE (a smoke constituent) induces
G:C-T:A transversions has predominantly been reported for the
p53 tumour suppressor gene in lung cancer (Hussain et al, 2001)
and may not apply to all genes and cancer sites, for example, not
one p53 G:C-T:A transversion was observed in smokers in a
study on bladder cancer (Spruck et al, 1993). Exposure to N-
nitrosamino compounds was associated with G : C-A : T transi-
tions in the RAS gene in tumours of rodents (Harris, 1991) and
also with VHL mutations in rats (Shiao et al, 1998). We found no
evidence to suggest that this plays a role in humans.
We are among the first to investigate the association of risk
factors with VHL mutations. A direct association between a risk
factor and mutations may give additional information on the
pathway(s) that lead to tumour growth. Previously, a positive
association of occupational exposure to trichloroethylene, an
industrial solvent, to VHL mutations and a hot spot for mutations
was observed in a case–control study (Brauch et al, 1999, 2004).
However, long-term exposure to an extremely high dose of the
probable carcinogen trichloroethylene was investigated. Decreased
risks were observed for vegetable consumption (for smokers) and
citrus consumption (for smokers and nonsmokers together) and
mutations in a case-only study (Hemminki et al, 2002). In this
report, the OR for risk of VHL mutations compared to wild-type
VHL as a result of smoking equalled 0.95 (95% CI: 0.41–2.21)
(Hemminki et al, 2002). This supports our observation that
smoking may not be associated with VHL mutations.
Smoking was associated with RCC risk for men, but smoking
was not associated with VHL mutations, irrespective of sex,
implying that smoking may cause or promote RCC independent
from VHL mutations.
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